Detalhe da pesquisa
1.
Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature.
Oncologist
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768082
2.
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.
Breast Cancer Res Treat
; 205(2): 267-279, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453781
3.
"Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors".
BMC Cancer
; 21(1): 1147, 2021 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34702204
4.
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort.
Br J Cancer
; 121(12): 991-1000, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31719684
5.
Efficacy of palbociclib plus fulvestrant after everolimus in hormone receptor-positive metastatic breast cancer.
Breast Cancer Res Treat
; 168(2): 559-566, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29247442
6.
Emerging PARP inhibitors for treating breast cancer.
Expert Opin Emerg Drugs
; 23(3): 211-221, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30251552
7.
TARGET: A phase I/II open-label multicenter study to assess safety and efficacy of fexagratinib in patients with relapsed/refractory FGFR fusion-positive glioma.
Neurooncol Adv
; 6(1): vdae068, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38813112
8.
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer.
JNCI Cancer Spectr
; 8(1)2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113421
9.
Intrathecal Catheter for Chemotherapy in Leptomeningeal Carcinomatosis From HER2-Negative Metastatic Breast Cancer.
J Breast Cancer
; 26(6): 572-581, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37704384
10.
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study.
Breast Cancer (Dove Med Press)
; 15: 311-325, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37139242
11.
Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study.
Cancers (Basel)
; 15(4)2023 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831532
12.
Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer.
Cancers (Basel)
; 14(10)2022 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35626113
13.
Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank?
Cancers (Basel)
; 14(22)2022 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428604
14.
Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor-Positive Recurrent or Metastatic Endometrial Cancer: The VICTORIA Multicenter, Open-label, Phase 1/2 Randomized Clinical Trial.
JAMA Oncol
; 8(7): 1001-1009, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551299
15.
Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes.
JAMA Netw Open
; 5(12): e2247154, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36520434
16.
[Practical management of PARP inhibitors: A French DELPHI consensus]. / Gestion pratique des inhibiteurs de PARP : Un consensus national DELPHI.
Bull Cancer
; 109(12): 1245-1261, 2022 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-36109248
17.
Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study.
Breast
; 65: 136-144, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944353
18.
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon.
Cancer Discov
; 12(6): 1435-1448, 2022 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398880
19.
A pharmacokinetic evaluation of alpelisib for the treatment of HR+, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer.
Expert Opin Drug Metab Toxicol
; 17(2): 139-152, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33213227
20.
Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes.
Genome Med
; 13(1): 174, 2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34749799